Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1551734 | 1.00 | GAA (0.38) | GAAHIF1AEPAS1ALOX15LMNA | |
| SCHEMBL10651515 | 0.81 | ALOX15 (0.44) | GAAHIF1AEPAS1ALOX15LMNA | |
| SCHEMBL11114925 | 0.79 | ALOX15 (0.38) | HIF1AEPAS1ALOX15LMNACYP3A4 | |
| SCHEMBL11114922 | 0.79 | ALOX15 (0.38) | HIF1AEPAS1ALOX15LMNACYP3A4 | |
| SCHEMBL12006013 | 0.75 | GAA (0.45) | GAAALOX15LMNACYP3A4 | |
| SCHEMBL9138775 | 0.73 | GAA (0.56) | GAALMNAALDH1A1 | |
| SCHEMBL111319 | 0.72 | ALOX15 (0.47) | HIF1AEPAS1ALOX15ALDH1A1 | |
| SCHEMBL11767058 | 0.72 | ALOX15 (0.47) | HIF1AEPAS1ALOX15ALDH1A1 | |
| SCHEMBL111320 | 0.72 | ALOX15 (0.47) | HIF1AEPAS1ALOX15ALDH1A1 | |
| SCHEMBL3358285 | 0.72 | ALOX15 (0.47) | GAAHIF1AEPAS1ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2211829-B1 | IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS | HENKEL AG & CO KGAA (DE) | 2011-04-27 | — | — | EP | claimed |
| US-20100210496-A1 | Fragrance Effect of Perfume Esters | BESSLER CORNELIUS | 2010-08-19 | — | — | US | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4593639-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250177298-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2025109106-A1 | CORE-SHELL MICROCAPSULES | XAMPLA Ltd. (GB) | 2025-05-30 | — | — | WO | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-20220095674-A1 | SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME | SUNSHO PHARMACEUTICAL CO., LTD. (JP) | 2022-03-31 | — | — | US | disclosed |
| US-9959392-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-05-01 | — | — | US | disclosed |
| CN-106999972-A | System and method for discharging fragrance | 阿甘芳香和精细化工有限公司 | 2017-08-01 | — | — | CN | disclosed |
| EP-2799863-A1 | Method to evaluate fragrance compositions | The Procter and Gamble Company (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-2799864-A1 | Method to evaluate fragrance compositions | The Procter and Gamble Company (US) | 2014-11-05 | — | — | EP | disclosed |
| US-20140221269-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2014-08-07 | — | — | US | disclosed |
| US-20100248390-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS | DUKE UNIVERSITY (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100210496-A1 | Fragrance Effect of Perfume Esters | BESSLER CORNELIUS | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | GAA 2863/4885HIF1A 1638/4885EPAS1 1959/4885 |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | LIPA, CUTA, MGLL | GAA 1306/4885HIF1A 1864/4885EPAS1 1783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.